220 related articles for article (PubMed ID: 17724283)
1. Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study.
Rapoport AM; Mathew NT; Silberstein SD; Dodick D; Tepper SJ; Sheftell FD; Bigal ME
Neurology; 2007 Aug; 69(9):821-6. PubMed ID: 17724283
[TBL] [Abstract][Full Text] [Related]
2. Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies.
Hedlund C; Rapoport AM; Dodick DW; Goadsby PJ
Headache; 2009 Oct; 49(9):1315-23. PubMed ID: 19788472
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study.
Cittadini E; May A; Straube A; Evers S; Bussone G; Goadsby PJ
Arch Neurol; 2006 Nov; 63(11):1537-42. PubMed ID: 16966497
[TBL] [Abstract][Full Text] [Related]
4. Oral zolmitriptan is effective in the acute treatment of cluster headache.
Bahra A; Gawel MJ; Hardebo JE; Millson D; Breen SA; Goadsby PJ
Neurology; 2000 May; 54(9):1832-9. PubMed ID: 10802793
[TBL] [Abstract][Full Text] [Related]
5. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
Gawel M; Aschoff J; May A; Charlesworth BR;
Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
[TBL] [Abstract][Full Text] [Related]
6. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
[TBL] [Abstract][Full Text] [Related]
7. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
Dodick D; Brandes J; Elkind A; Mathew N; Rodichok L
CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326
[TBL] [Abstract][Full Text] [Related]
8. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of zolmitriptan nasal spray for the treatment of acute migraine in adolescents: Results of a randomized, double-blind, multi-center, parallel-group study (TEENZ).
Winner P; Farkas V; Štillová H; Woodruff B; Liss C; Lillieborg S; Raines S;
Headache; 2016 Jul; 56(7):1107-19. PubMed ID: 27329280
[TBL] [Abstract][Full Text] [Related]
10. Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents.
Rothner AD; Wasiewski W; Winner P; Lewis D; Stankowski J
Headache; 2006 Jan; 46(1):101-9. PubMed ID: 16412157
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of zolmitriptan nasal spray in adolescent migraine.
Lewis DW; Winner P; Hershey AD; Wasiewski WW;
Pediatrics; 2007 Aug; 120(2):390-6. PubMed ID: 17671066
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
Tuchman M; Hee A; Emeribe U; Silberstein S
CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
[TBL] [Abstract][Full Text] [Related]
13. Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial.
Dowson AJ; Charlesworth BR; Green J; Färkkilä M; Diener HC; Hansen SB; Gawel M;
Headache; 2005 Jan; 45(1):17-24. PubMed ID: 15663608
[TBL] [Abstract][Full Text] [Related]
14. Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study.
van Vliet JA; Bahra A; Martin V; Ramadan N; Aurora SK; Mathew NT; Ferrari MD; Goadsby PJ
Neurology; 2003 Feb; 60(4):630-3. PubMed ID: 12601104
[TBL] [Abstract][Full Text] [Related]
15. [Experience with intranasal zolmitriptan in cluster headache].
Pascual J; Navarro A; Caminero AB; Jurado C
Neurologia; 2006 Apr; 21(3):131-4. PubMed ID: 16575626
[TBL] [Abstract][Full Text] [Related]
16. Zolmitriptan nasal spray: advances in migraine treatment.
Syrett N; Abu-Shakra S; Yates R
Neurology; 2003 Oct; 61(8 Suppl 4):S27-30. PubMed ID: 14581655
[TBL] [Abstract][Full Text] [Related]
17. A multicenter, randomized, double-blind, placebo-controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 11 years, with an open-label extension.
Yonker ME; McVige J; Zeitlin L; Visser H
Headache; 2022 Oct; 62(9):1207-1217. PubMed ID: 36286602
[TBL] [Abstract][Full Text] [Related]
18. Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet.
Spierings EL; Rapoport AM; Dodick DW; Charlesworth B
CNS Drugs; 2004; 18(15):1133-41. PubMed ID: 15581383
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and satisfaction with zolmitriptan 5 mg nasal spray for treatment of migraine in real-life practice: results of a postmarketing surveillance study.
Diener HC; Evers S
Clin Drug Investig; 2007; 27(1):59-66. PubMed ID: 17177580
[TBL] [Abstract][Full Text] [Related]
20. Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group.
Rapoport AM; Ramadan NM; Adelman JU; Mathew NT; Elkind AH; Kudrow DB; Earl NL
Neurology; 1997 Nov; 49(5):1210-8. PubMed ID: 9371896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
